Organizing Committee Members - Cancer Survivorship 2018
University of Huddersfield
Nik received his BSc (Biochemistry & Genetics) and his PhD at the University of Leeds. This was followed by a post-doctoral fellowship at the Cancer Research UK Centre (St Jamesâ€™ Hospital, Leeds) and an EPSRC-funded fellowship in the Jack Birch Unit of Molecular Carcinogenesis (University of York). Following that, he moved to the Department of Biological Sciences at the University of Huddersfield where he is currently a Reader (Associate Professor) in Cell Biology.
Nik Georgopoulos(Research Area)
Nikâ€™s research focuses on understanding how the process of epithelial cancer development influences proliferation/growth, differentiation and particularly cell responses to death signals triggered by members of the TNF Receptor (TNFR) family of proteins. The aim is to use such knowledge to design novel, tumour-specific anticancer therapies. Currently he is developing a novel platform of cancer therapeutics based on the TNFR family (ThanatoCureâ„¢). His skin-related research involves using biological models to explore, at the cellular and molecular level, the underlying mechanisms of defective wound healing and chemotherapy-induced alopecia. This will permit the improvement of existing medical devices and design of novel technologies to provide improved therapeutic intervention strategies. Nik has a major industrial collaboration on skin-related research with Paxman (http://paxman-coolers.com).
Chulalongkorn University, Bangkok
Professor Viroj Wiwanitkit is a medical professor and Asian Scholar. He is presently a visiting University Professor, Hainan Medical University, China. He has more than 950 international journal publications and 150 international textbook publications. He is editor in chief and editorial board of more than 40 journals. He has ever been invited to be keynote speakers of many international conferences. He is the Thai scientists with the most number of publications. He is a guest lecturer of many universities.
Viroj Wiwanitkit(Research Area)
Infectious disease Tropical medicine Public health Laboratory medicine Informatics
Director & Associate Professor
Virginia Commonwealth University
Khalid Matin, M.D., F.A.C.P., has been appointed as a medical director of community oncology and clinical research affiliations at VCU Massey Cancer Center and an associate professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the VCU School of Medicine, effective July 15, 2013. Most recently, Matin was director of community oncology and associate professor of oncology at Roswell Park Cancer Institute in Buffalo, New York. He was also an attending physician at Roswellâ€™s satellite facility in Amherst, NY. Prior to his roles at Roswell, Matin was a medical oncologist at the Cancer Center of Montgomery, Alabama, which is part of the Southeast Cancer Network; a clinical assistant professor at the University of Alabama in Birmingham and University of Pittsburgh Cancer Institute in Pennsylvania; and attending physician in hematology-oncology at the Veterans Affairs Medical Center in Pittsburgh. A board-certified medical oncologist and clinical researcher, Matin is an expert in the study and treatment of gastrointestinal (GI) cancers. He has developed several clinical trials for GI cancers, and he has served as the principal investigator and co-investigator on various colorectal and lung cancer trials.
Khalid Matin(Research Area)
Matin is an expert in the study and treatment of gastrointestinal (GI) cancers. He has developed several clinical trials for GI cancers and lung cancer.
European University Cyprus
Ioannis S. Patrikios (Biography)
Professor Ioannis S. Patrikios received his BSc degree in Pre-Medical studies/Biochemistry from the City College of the City University of NY. He completed his PhD studies in 1994, specialized on Immunology and Lipids/Lipidomics and post-doctoral studies specialization in Medical Biochemistry at the City College of NY, next to the world-known Professor CS Russell. Professor Patrikios went through several different fellowships including research specializations /collaborations with different high reputation institutions including, Mount Sinai NY and was awarded advanced Immunology specialization courses at Scuola Superiore d'Immunologia Ruggero Ceppellini, Italy. He served and continues to serve as a Research Scientific Consultant for Industry and higher education. His broad research interests include studies of new therapeutic approaches of chronic diseases by the use of Systems Medicine, through Systems Biology and Nutritional Systems Biology; Lipid Hemagglutinins, Lectins, Immunology and the use of novel interventions against Metastatic Tumor Cells. As from 2004, Professor Patrikios got involved in the research of innovative, pioneer, holistic therapeutic approaches for chronic multifactorial Neurodegenerative diseases, specifically of Multiple Sclerosis. He is affiliated as a Graduate Studies Mentor with the Institute of Brain Chemistry of London. During the last decade he has obtained many competitive research grants, participated in several different collaborative European scientific research-projects and he organized several large European Consortium Platforms for research and Clinical Trials. His 2002 research findings on the effect of frying oils as human hemagglutinins got an international interest; and have been discussed by several different National Food and Drug Administrations, including UK, and through articles in high impact Magazines such as the New Scientist. He has lately been honored with the tittle of a fellow and member of the advisory board of the Forensic Pathology Academy of London. He has been appointed as a reviewer and editor of several international scientific journals in the field of Medicine, Med-Biochemistry, Pharmaceuticals-Therapeutics and Neurology and as a reviewer for research grants. He is the solid author of University Books in Biochemistry and Medical Biochemistry and he has authored numerous peer-reviewed, limited co-authored original publications, in high impact factor scientific journals. Professor Patrikios is a member of several International associations and bodies including Sigma Xi. He is the chief scientific investigator of the team which lately invented and patented the nutraceutical formula PLP10 as a new therapeutic intervention for multiple sclerosis. He is the co-founder and Director of PALUPA Medical Ltd (a research and innovation company), that performed and successfully completed the phase II clinical trial for PLP10. Now he is the scientific coordinator of the â€œMINERALâ€ phase III multicenter clinical trial for PLP10. At present he is a Professor, Faculty of Medicine and the Chairman of the School of Medicine of the European University of Cyprus and affiliated as a research collaborator at the Cyprus Institute of Neurology and Genetics.
Ioannis S. Patrikios (Research Area)
His 2002 research findings on the effect of frying oils as human hemagglutinins got an international interest, and have been discussed by several different National Food and Drug Administrations
Oliver Micke has completed his PhD at the age of 35 years from Muenster University Hospital in 2006. He is head of the Head of the department for radiotherapy and radiation oncology at the Franziskus Hospital Bielefeld since 2006. In addition, he is the medical director of Franziskus Hospital Bielefeld, a premier teaching hospital of the Medical University of Hanover (MHH). He has published more than 200 papers in reputed national and international journals and has been serving as a reviewer as well as an editorial board member of repute.
Oliver Micke(Research Area)
Radiation Oncology, Breast Cancer, Prostate Cancer, Modern and Advanced Radiotherapy Treatment Techniques, Reirradiation, Cytoprotection, Radiotherapy for Rare Diseases, Radiotherapy for Benign Disorders, Complementary and Alternative Medicine, Selenium, Magnesium, Trace Elements and Electrolytes
Nigde Ã–mer Halisdemir University
Zeliha Selamoglu (Biography)
Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ã–mer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 80 peer-reviewed journal articles with over 700 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals. h-index: 14 citations: 735
Zeliha Selamoglu (Research Area)
Molecular Biology, Biochemistry, Biotechnology, Oxidative stress, Antioxidants, Cancer.
National University of Ireland
Eva Szegezdi is a research lecturer in cancer biology and principal investigator of the Apoptosis Research Centre at the National University of Ireland, Galway. Dr` Szegezdi received her PhD in medical science in 2000 studying cell death signalling in thymocytes at the University of Debrecen, Hungary. She joined the Cell Stress and Apoptosis Research laboratory led by Prof. Afshin Samali at the National University of Ireland, Galway in 2001 to study endoplasmic reticulum stress-induced cell death in heart and pancreatic cells and later death receptor signal transduction in cancer. She received a Science Foundation Ireland Starting Investigator Research Award and an Irish Cancer Society Research Fellow award in 2010 and established her research group focusing on systems biology of death receptor signal transduction in cancer. She took up a lectureship position in the Discipline of Biochemistry, National University of Ireland, Galway in 2011.
Eva Szegezdi(Research Area)
Current research in her laboratory focuses on the systems-level analysis of signal transduction networks in cancer cells. Particular focus is the tumour-microenvironment crosstalk in leukaemia and identifies a mechanism how the microenvironment can be altered to reject leukemic cells. Eva Szegezdi also acts as the founding director of Blood Cancer Biobank Ireland, director of the MSc programme in Cancer Research in NUIG and coordinator of the H2020-RISE programme, DISCOVER.
National Cancer Institute of Naples
Dr.Francesco Izzo received his medical degree from the University of Naples, Federico II Medical School, Italy. He completed a general surgery residency at the University of Naples, Italy and then completed a fellowship in Surgical Oncology at the University of Texas Anderson Cancer Center. Dr. Izzo has been on the faculty in the Department of Surgical Oncology at the National Cancer Institute of Naples, Italy since completing his fellowship. He is now Full Professor of Surgery, Director and Coordinator of the Abdominal and Hepatobiliary Surgical Oncology Division and Chief of Liver Tumor Study Group at the National Cancer Institute of Naples, Italy. Dr. Izzoâ€™s clinical practice and research focuses on surgical oncology new treatments particularly for patients with Hepatobiliary and pancreatic tumors. Dr.Izzo has been a pioneer in designing new treatments for patients with liver tumors, including radiofrequency ablation, improved techniques for surgical removal of liver cancers, and several types of direct tumor injection therapy. Dr Izzo is principal investigator on a number of National and International protocols for the basic science and clinical treatment on primary and metastatic hepato-biliary cancers Dr.Izzo is the author or co-author of over 220 publications, 20 book chapters, many dealing with the treatment of patients with hepatocellular cancer, gallbladder cancer, bile duct cancer, pancreatic cancer or metastases from a number of different tumor types. Is Total Impact Factor: 638,003 ; H-INDEX: 35; Sum of the times cited: 7.017; Database utilized: SCOPUS for H-Index and Bibliosan for IF
Francesco Izzo(Research Area)
California South University
Dr. Alireza Heidari(Biography)
Dr. Alireza Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Netherlands, Russia, France, Swiss, Germany, Sweden, Spain, Portugal, South Korea, China, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than ten books in Chemistry. Syne, he has been awarded more than four hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals. Hitherward, he is a member of more than one hundred reputed international academicâ€“scientificâ€“research institutes around the world.
Dr. Alireza Heidari(Research Area)
Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure.